Article Text

PDF
Observational prospective study of the effectiveness in routine clinical practice of verteporfin photodynamic therapy in patients with neovascular age-related macular degeneration
  1. S Murjaneh1,
  2. M García-Fiñana2,
  3. S Mahmood1,
  4. P M Lenfestey1,
  5. S A Taylor1,
  6. I A Pearce1,
  7. M C Briggs1,
  8. H Heimann1,
  9. S P Harding1
  1. 1
    St Paul’s Eye Unit, Royal Liverpool University Hospital, Liverpool, UK
  2. 2
    Centre for Medical Statistics and Health Evaluation, University of Liverpool, Liverpool, UK
  1. Professor S P Harding, Consultant Ophthalmic Surgeon, St Paul’s Eye Unit, Royal Liverpool University Hospital, Prescot Street, Liverpool L7 8XP, UK; s.p.harding{at}liverpool.ac.uk

Abstract

Aims: To investigate effectiveness in routine clinical practice of verteporfin photodynamic therapy (PDT) for neovascular age-related macular degeneration (nAMD).

Patients and methods: Patients commencing PDT for nAMD in a single UK centre entered a prospective observational 7-year study and were followed for 2 years. Best-corrected visual acuity (BCVA) and contrast sensitivity (CS) were measured at each visit by accredited technicians after full protocol refraction on standardised charts. Reasons for failure to complete the course of therapy were documented.

Results: 1008 patients entered the study between 1999 and 2006. 81% and 52% completed 12 and 24 months’ follow-up respectively (excluding administrative censoring). Results at 12 and 24 months respectively were: maintenance of BCVA 62%, 63%; drop in mean BCVA (letters) 10.1, 9.4; numbers of treatments 2.9, 3.5. The mean CS remained stable. No correlation of change in BCVA outcome between first and second treated eyes in 82 bilateral cases was detected. Loss to follow-up was significantly associated with age, CS and distance from the treating centre.

Conclusions: PDT delivered in clinical practice is at least as effective as that reported in randomised clinical trials and uses fewer treatments.

Statistics from Altmetric.com

Footnotes

  • Competing interests: St Paul’s Eye Unit has received departmental commercial funding as a clinical centre in the TAP and VIP studies. SAT, IAP, MCB, HH and SPH have received support for travel and conference attendance.

  • Patient consent: Obtained.

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

Linked Articles

  • At a glance
    Harminder S Dua Arun D Singh